Alexander S. Young

Alexander S. Young

Auto-generated profile, based on publicly available information

Alexander S. Young

Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, United States

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in American Journal of Psychiatry
Verified
Journal Article
Closed access
KNKeith H. Nuechterlein
Keith H. Nuechterlein
MGMichael F. Green
Michael F. Green
RKRobert S. Kern
Robert S. Kern
LBLyle E. Baade
Lyle E. Baade
DBDeanna M. Barch
Deanna M. Barch
SMStephen R. Marder
Stephen R. Marder

1 January 2001 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
AYAlexander S. Young
Alexander S. Young
RKRuth Klap
Ruth Klap
CSCathy D. Sherbourne
Cathy D. Sherbourne
KWKenneth B. Wells
Kenneth B. Wells
DEPRESSIVE AND anxiety disorders are common and have a substantial impact on functioning and quality of life. National treatment guidelines for major depression document that effective treatments include antidepressant medications and cognitive-behavioral and interpersonal psychotherapies.1-5 Research also supports the efficacy of these treatments for dysthymia, although the literature is less well developed.5-9 In panic disorder, treatment guidelines strongly support the efficacy of cognitive-behavioral psychotherapies, some antidepressant medications, and benzodiazepines.10,11 In generalized anxiety disorder (GAD), effective treatments include antidepressant medications, buspirone, benzodiazepines, cognitive-behavioral psychotherapies, and probably relaxation and unstructured therapy techniques.12-15 Although these treatments are effective, patients frequently do not receive them.16 However, there have been few national studies of the quality of mental health care. Researchers have successfully characterized national quality of care for a variety of medical disorders,17 and it is important to know whether similar research in psychiatry can provide data to inform policy nationally. While the existing literature suggests that quality of care for common psychiatric disorders is moderate to poor across different types of treatment settings, national data are limited and not clinically detailed, and it is unclear which populations are at greatest risk for not receiving appropriate care.

1 November 2000 in American Journal of Psychiatry
Verified
Journal Article
Closed access
JUJürgen Unützer
Jürgen Unützer
RKRuth Klap
Ruth Klap
RSRoland Sturm
Roland Sturm
AYAlexander S. Young
Alexander S. Young
TMTonya Marmon
Tonya Marmon
KWKenneth B. Wells
Kenneth B. Wells

1 March 2007 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
DDDavid Dorr
David Dorr
LBLaura M. Bonner
Laura M. Bonner
ACAmy N. Cohen
Amy N. Cohen
RSR. S. Shoai
R. S. Shoai
RPR. Perrin
R. Perrin
AYA. S. Young
A. S. Young
Objective: To understand information systems components important in supporting team-based care of chronic illness through a literature search.Design

30 March 2006 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
HGHoward H. Goldman
Howard H. Goldman
RFRichard G. Frank
Richard G. Frank
MBM. Audrey Burnam
M. Audrey Burnam
HHHaiden A. Huskamp
Haiden A. Huskamp
MRM. Susan Ridgely
M. Susan Ridgely
MBMargaret Blasinsky
Margaret Blasinsky
To improve insurance coverage of mental health and substance-abuse services, the Federal Employees Health Benefits (FEHB) Program offered mental health and substance-abuse benefits on a par with general medical benefits beginning in January 2001. The plans were encouraged to manage care. We compared seven FEHB plans from 1999 through 2002 with a matched set of health plans that did not have benefits on a par with mental health and substance-abuse benefits (parity of mental health and substance-abuse benefits). Using a difference-in-differences analysis, we compared the claims patterns of matched pairs of FEHB and control plans by examining the rate of use, total spending, and out-of-pocket spending among users of mental health and substance-abuse services. The difference-in-differences analysis indicated that the observed increase in the rate of use of mental health and substance-abuse services after the implementation of the parity policy was due almost entirely to a general trend in increased use that was observed in comparison health plans as well as FEHB plans. The implementation of parity was associated with a statistically significant increase in use in one plan (+0.78 percent, P<0.05) a significant decrease in use in one plan (−0.96 percent, P0.05 for each comparison). For beneficiaries who used mental health and substance-abuse services, spending attributable to the implementation of parity decreased significantly for three plans (range, −$201.99 to −$68.97; P0.05 for each comparison). The implementation of parity was associated with significant reductions in out-of-pocket spending in five of seven plans. When coupled with management of care, implementation of parity in insurance benefits for behavioral health care can improve insurance protection without increasing total costs.

1 July 2002 in Psychiatric Services
Verified
Journal Article
Closed access
PDF file
JCJulie Cradock-O'Leary
Julie Cradock-O'Leary
AYAlexander S. Young
Alexander S. Young
EYElizabeth M. Yano
Elizabeth M. Yano
MWMingming Wang
Mingming Wang
MLMartin L. Lee
Martin L. Lee